| Application no. and date | 13703243.9 (espacenet) (Federated) (European Patent Register), 20130125 | | Patent/reg. no. and date | DK/EP 2806859, 20190515 | | Publication date | 20141203 | | Priority no. and date | US 201261590479 P, 20120125, US 201261651218 P, 20120524, US 201261691898 P, 20120822, US 201261708691 P, 20121002 | | EP pub. no. and date |
EP 2806859 20141203 | | Effective date | | | Applicant/owner | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | | Applicant ref. no. | P69279dk01 | | Inventor | VERWIJIS, Marinus, Jacobus, 4 Carter Drive
Framingham, MA 01701, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/443 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , C07D 213/75 (2006.01) , C07D 405/12 (2006.01) , C07D 405/14 (2006.01) | | Title | FORMULERINGER AF 3-(6-(1-(2.2-DIFLUORBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANCARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOESYRE | | Int. application no. | US2013023100 | | Int. publication no. | WO2013112804 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
